Jay Chun, M.D., Ph.D.
Board Member
Semnur Pharmaceuticals, Inc. (SMNR)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jay Chun, M.D., Ph.D.
Jay Chun, M.D., Ph.D. is recorded as Board Member at Semnur Pharmaceuticals, Inc. (SMNR). Semnur Pharmaceuticals, Inc. reported in an 8-K filed September 26, 2025 that Jay Chun, M.D., Ph.D. was appointed Class I director, effective September 22, 2025.
“Effective as of the Closing, the following people were appointed as directors of the Company: Class I director: Jay Chun, M.D., Ph.D. and Annu Navani, M.D.;”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-09-22–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Semnur Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Henry Ji CEO
- Jaisim Shah CEO, Board Member
- Henry Ji, Ph.D. Chairman, Board Member
- Stephen Ma CFO, COO
- Annu Navani, M.D. Board Member
- Dorman Followwill Board Member
- Huifeng Chang Board Member
- Jim Mao Board Member
- Kevin D. Vassily Board Member
- Kevin Vassily Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.